Dawn R Dufield

Title: Dawn R Dufield: Innovator in Peptide Biomarkers

Introduction

Dawn R Dufield is a notable inventor based in O'Fallon, MO (US). She has made significant contributions to the field of biomedical research, particularly in the identification and quantification of peptides. Her work has implications for understanding various diseases and physiological conditions.

Latest Patents

Dufield holds a patent for a "Peptide biomarker and method of identification." This innovative method involves identifying and quantifying peptides resulting from enzyme cleavage of collagen type II through mass spectrometric analysis. The technique detects characteristic peptide fragments of a carboxy-terminus with known mass-to-charge ratios, allowing for the identification of specific peptides. This method is particularly useful in assessing the activity of proteolytic enzymes in diseases such as osteoarthritis and rheumatoid arthritis, as well as evaluating the efficacy of enzyme-blocking agents. She has 1 patent to her name.

Career Highlights

Dufield has worked at Pharmacia Corporation, where she has been able to apply her expertise in peptide biomarker research. Her role at the company has allowed her to contribute to advancements in the understanding of proteolytic enzymes and their impact on health.

Collaborations

Dufield has collaborated with notable colleagues, including Dean James Welsch and Kevin L Duffin. These partnerships have enhanced her research and contributed to the development of innovative solutions in her field.

Conclusion

Dawn R Dufield is a pioneering inventor whose work in peptide biomarkers has the potential to transform the understanding and treatment of various diseases. Her contributions to biomedical research continue to make a significant impact.